Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12

Dr Duncan Gilbert - Sussex Cancer Centre, Brighton , UK
Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12 ( Dr Duncan Gilbert - Sussex Cancer Centre, Brighton , UK )
25 Feb 2013

Clinical trials and laboratory research

Prof Jonathan Ledermann - University College London, UK
Clinical trials and laboratory research ( Prof Jonathan Ledermann - University College London, UK )
14 Feb 2013

Advances in multiple myeloma from ASH 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France
Advances in multiple myeloma from ASH 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (2/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (1/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (1/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Multiple myeloma advances for the future suggested by phase I clinical research

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Investigation of Ki67 biomarker

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Investigation of Ki67 biomarker ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
17 Dec 2012

Results of a randomised phase 2 study of PD 0332991

Dr Richard Finn - Universtity of California, Los Angeles, USA
Results of a randomised phase 2 study of PD 0332991 ( Dr Richard Finn - Universtity of California, Los Angeles, USA )
17 Dec 2012

MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
17 Dec 2012

PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML) ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
17 Dec 2012

Links between EGFR/HER1 signalling and trastuzumab efficacy

Dr David Rimm – Yale University, New Haven, USA
Links between EGFR/HER1 signalling and trastuzumab efficacy ( Dr David Rimm – Yale University, New Haven, USA )
16 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation